In a significant/important/landmark development for the treatment of spinal muscular atrophy (SMA), the Delhi High Court has upheld/approved/supported the regulatory approval/permission/sanction for the drug risdiplam https://brontefnov346476.blog-gold.com/50972063/hc-upholds-official-approval-for-risdiplam-in-india